Psoriasis and eczema are two of the most common chronic skin conditions seen at our clinic in Greater Kailash Part-1 — and two of the most commonly managed poorly. Not because effective treatments do not exist, but because both conditions are frequently approached as acute problems rather than the chronic, relapsing-remitting diseases they actually are. A patient presents with a flare, receives a short course of a topical steroid, improves temporarily, stops treatment, and returns months later with a worse flare than the one before. This cycle — repeated over years — produces progressive skin damage, steroid dependence, and deepening frustration.
What changes this pattern is a shift in how the conditions are understood and managed: not as isolated flares to be extinguished, but as ongoing biological processes that require structured, long-term management plans tailored to the specific triggers, severity, and skin type of the individual patient. In Delhi specifically — with its extreme seasonal variation, pollution load, hard water, and high-stress urban environment — psoriasis treatment delhi and eczema treatment south delhi require an approach that accounts for the environmental drivers that are unique to this city.
Key Takeaways
- These Are Chronic Conditions, Not Acute Events: Psoriasis and eczema require long-term management plans — not just flare treatment. The goal is sustained control, not a single cure.
- Psoriasis and Eczema Are Biologically Distinct: They look similar but have completely different inflammatory pathways — IL-17/IL-23 in psoriasis, Th2-driven in atopic dermatitis — requiring different treatment approaches.
- Steroid Overuse Is the Most Common Management Error: Long-term use of potent topical steroids without medical supervision causes skin thinning, rebound flares, and, in some cases, systemic effects.
- Trigger Identification Is Treatment: Identifying and modifying specific triggers — stress, certain foods, environmental exposures, contact allergens — is as clinically important as prescribing medication.
- Delhi’s Environment Adds Specific Pressure: Pollution, hard water, extreme seasonal temperature swings, and high ambient stress levels all contribute to flare frequency in both conditions.
Psoriasis: What Is Actually Happening in the Skin
Psoriasis treatment delhi patients often arrive believing their condition is primarily a skin problem. It is not. Psoriasis is a systemic immune-mediated disease — the skin manifestation is the visible expression of an immune dysregulation that affects the whole body. The primary pathological event is an abnormal T-lymphocyte activation that drives excessive keratinocyte proliferation: skin cells in affected areas complete their growth cycle in three to five days rather than the normal 28 days, accumulating at the surface faster than they can shed. This produces the characteristic silvery scale over a red, inflamed base — the psoriatic plaque.
The key inflammatory drivers are the IL-17 and IL-23 pathway: interleukins produced by activated T-cells that signal the keratinocytes to proliferate abnormally and produce further pro-inflammatory cytokines. This is why the most effective systemic treatments for psoriasis — including biologics psoriasis india — target these specific cytokines rather than applying blanket immunosuppression. It is also why topical steroids alone, which suppress inflammation broadly without addressing the upstream driver, produce temporary improvement followed by rebound when stopped.
The Koebner Phenomenon
One of the most clinically important features of psoriasis for Delhi patients is the Koebner phenomenon: psoriatic lesions can be triggered at sites of physical trauma to the skin. Scratching, friction from clothing, insect bites, injections, and even the irritation from hard water can trigger new plaques in previously clear skin. This has direct practical implications for daily management — protecting the skin from physical trauma, using soft fabrics, managing mosquito exposure, and avoiding harsh soaps and hard water on lesional skin are clinical recommendations, not lifestyle suggestions.
Assessing Severity: The PASI Score
The PASI score (Psoriasis Area and Severity Index) is the standard clinical tool for quantifying psoriasis severity — scoring the area of involvement and the intensity of redness, scaling, and thickness across body regions. It determines which treatment tier is appropriate: mild disease (PASI under 10, limited body surface area) is managed with topical treatments; moderate-to-severe disease (PASI 10 and above, or significant impact on quality of life despite topical treatment) warrants consideration of phototherapy, conventional systemic agents, or biologics psoriasis india.
Eczema (Atopic Dermatitis): The Barrier-First Disease
Atopic dermatitis delhi — the most common form of eczema — is fundamentally a disease of skin barrier dysfunction combined with immune dysregulation. The skin barrier in atopic dermatitis patients has a structural deficiency — often involving mutations in filaggrin, a key barrier protein — that allows environmental allergens, irritants, and microorganisms to penetrate the skin more easily than normal. This penetration triggers a Th2-dominated immune response: the skin becomes inflamed, intensely itchy, and releases histamine and cytokines that drive the itch-scratch cycle — scratching damages the barrier further, allowing more penetration, driving more inflammation.
The practical consequence of this barrier-first pathology is that emollient barrier repair is not a supplementary element of eczema treatment — it is the foundation. Patients who do not apply emollients consistently and generously between flares have a higher flare frequency, more severe flares, and need more topical steroid to manage them. The emollient fills the structural gaps in the barrier, reduces water loss, prevents allergen penetration, and reduces the immune provocation that drives flares. In Delhi, where pollution particles and hard water are additional barrier stressors, this principle is amplified further.
Contact Dermatitis: The Eczema That Is Not Atopic
Patch testing contact dermatitis is an essential clinical investigation for any patient presenting with eczema that does not follow the expected distribution, does not respond predictably to standard treatment, or occurs in an adult without childhood atopic history. Contact dermatitis — immune-mediated reaction to a specific allergen in contact with the skin — is frequently misdiagnosed as atopic eczema and treated accordingly, with partial response. Common culprits in South Delhi patients include nickel (jewellery, belt buckles), fragrances, preservatives in cosmetics and skincare products, rubber compounds, and certain topical medications. Patch testing identifies the specific allergen — avoidance is then curative.
How Delhi’s Environment Drives Flares in Both Conditions
Both psoriasis and atopic dermatitis are triggered and worsened by environmental stressors — and Delhi’s environment is particularly rich in them:
- Air pollution (PM2.5 and PM10): Particulate matter deposits on skin, disrupts the barrier, and triggers inflammatory cytokine production. Both conditions flare more frequently in Delhi’s high-pollution months (October through January) than in comparable patients in less polluted environments.
- Hard water: Delhi’s municipal water has high calcium and magnesium content. Bathing in hard water damages the skin barrier by removing natural lipids and leaving a mineral film that irritates sensitised skin. Patients with atopic dermatitis in particular often note worsening that correlates with water source changes.
- Extreme seasonal temperature shifts: The transition from extreme summer heat to monsoon humidity, and from monsoon to dry winter cold, represents a rapid environmental shift that consistently precipitates flares in both psoriasis and eczema patients. Having a management plan that anticipates these transitions — not just reacts to them — is the difference between controlled and uncontrolled disease.
- Stress: Psychological stress is one of the most reproducible psoriasis triggers — it activates the hypothalamic-pituitary-adrenal axis and produces neuroimmune signals that drive psoriatic flares. Delhi’s high-pressure professional environment means stress management is a clinical topic in every psoriasis doctor greater kailash consultation, not a soft recommendation.
Treatment Approaches: What Is Used and When
Topical Corticosteroids — The Right Way to Use Them
Topical corticosteroids are the most widely used and effective topical treatments for both psoriasis and eczema — but they must be used correctly. The correct application is: the appropriate potency for the area and severity (low potency for face and flexures, higher potency for thick plaques on the trunk and limbs), applied to active lesions only for defined treatment courses, then stepped down and replaced with steroid-sparing agents for maintenance. The incorrect use — which produces the skin thinning, striae, and rebound flares seen so commonly in self-treating patients — is continuous, prolonged application of potent steroids to large areas without medical supervision, or use of combined steroid-antifungal preparations on eczematous skin for extended periods.
Calcineurin Inhibitors
Calcineurin inhibitors — topical tacrolimus and pimecrolimus — are steroid-sparing agents used for eczema management in sensitive areas (face, eyelids, neck flexures) where topical steroids carry the highest risk of skin thinning. They are particularly useful for long-term maintenance in atopic dermatitis, reducing flare frequency when applied two to three times per week to previously affected areas even when the skin appears clear — a strategy called proactive therapy that is significantly more effective than reactive treatment in patients with frequently relapsing disease.
Wet Wrap Therapy for Eczema
Wet wrap therapy eczema is an effective intervention for severe atopic dermatitis flares — particularly in children — that does not respond adequately to standard topical treatment. A diluted topical steroid or emollient is applied to the affected skin, covered with a damp layer of tubular bandage, then a dry outer layer. The occlusion drives rapid penetration of the topical agent and provides mechanical protection from scratching. It is performed under dermatologist supervision, not independently, due to the risk of systemic steroid absorption with prolonged use.
Biologics for Moderate-to-Severe Psoriasis
The introduction of biologics psoriasis india — specifically IL-17 inhibitors (secukinumab, ixekizumab) and IL-23 inhibitors (guselkumab, risankizumab) — has transformed the management of moderate-to-severe psoriasis. These targeted agents block the specific cytokine pathways driving psoriatic inflammation, producing skin clearance rates (PASI 90 and PASI 100) that were not achievable with conventional systemic treatments. They are administered by injection every four to twelve weeks depending on the agent. In India, several of these agents are now available and increasingly accessible — they are prescribed and monitored under specialist dermatologist supervision.
Psoriasis vs Eczema: Key Clinical Differences
| Feature | Psoriasis | Atopic Eczema |
|---|---|---|
| Appearance | Well-defined plaques, thick silvery scale | Poorly defined, weeping, crusting patches |
| Itch | Mild to moderate | Intense — drives the scratch-itch cycle |
| Common Sites | Elbows, knees, scalp, lower back | Flexures, face, neck, hands |
| Key Pathway | IL-17 / IL-23 (Th1/Th17) | Th2-driven, IgE mediated |
| Barrier Defect | Secondary to inflammation | Primary — filaggrin deficiency |
| Koebner Effect | Yes — trauma triggers new plaques | No direct equivalent |
| Nail Involvement | Common — pitting, onycholysis | Rare |
“The patients who manage psoriasis or eczema well in Delhi are the ones who understand their condition deeply enough to anticipate flares — not just react to them. Seasonal transitions, stress events, and environmental changes are predictable. The management plan should address them before they hit.” — Dr. Rajat Kandhari
For a structured assessment and long-term management plan for chronic skin condition treatment delhi, book a consultation at Dr. Rajat Kandhari’s clinic — S-79, Greater Kailash Part-1, South Delhi. Open Monday to Saturday, 9am to 8pm. Call or WhatsApp: +91 9315479193.
Frequently Asked Questions
Q1. Is psoriasis curable?
Psoriasis is a chronic condition — there is currently no cure that permanently eliminates the underlying immune dysregulation. However, it is very effectively manageable: with appropriate treatment, most patients achieve sustained skin clearance or near-clearance. Biologics psoriasis india now produce PASI 90 and PASI 100 clearance in a significant proportion of moderate-to-severe patients. The goal of treatment is sustained remission and minimal impact on quality of life, not a single cure event.
Q2. How do I know if my skin condition is psoriasis or eczema?
The key distinguishing features are the appearance and distribution. Psoriasis produces well-defined plaques with thick silvery scale, typically on elbows, knees, and scalp. Eczema produces poorly defined, intensely itchy, weeping or crusting patches, typically in flexural areas (inside elbows, behind knees) and on the face. Both can occur together — and seborrhoeic dermatitis scalp delhi has features of both. A dermatologist examination establishes the diagnosis; patch testing contact dermatitis is added when contact allergy is suspected.
Q3. Why does my eczema keep coming back even after it clears?
Atopic eczema recurs because the barrier defect and immune sensitisation that cause it are structural and ongoing — they do not resolve when a flare clears. Without consistent emollient barrier repair between flares and avoidance of triggers, the next flare is a matter of when, not if. Proactive therapy — applying calcineurin inhibitors or low-potency steroids to previously affected areas two to three times per week even when clear — significantly reduces relapse frequency.
Q4. Is it safe to use topical steroids long-term for eczema?
Topical corticosteroids are safe and effective when used correctly — the right potency for the area and severity, for defined treatment courses, stepped down appropriately. Long-term continuous use of potent steroids, particularly on sensitive areas, causes skin thinning, striae, and rebound flares. A dermatologist prescribes the appropriate agent with clear instructions on duration and step-down — self-medicating with potent steroids indefinitely is what produces the adverse effects patients attribute to the medication itself.
Q5. What triggers psoriasis flares in Delhi specifically?
The most consistent triggers in South Delhi patients are: psychological stress (extremely common in the city’s professional environment), the seasonal transitions (summer to monsoon, monsoon to winter), pollution-related barrier disruption, infections (particularly streptococcal throat infections for guttate psoriasis), and — in patients on certain medications — beta-blockers, lithium, and antimalarials. The Koebner phenomenon means any skin trauma — including insect bites and friction from clothing — can trigger new plaques in susceptible skin.
Q6. Who qualifies for biologic treatment for psoriasis in India?
Biologics are indicated for patients with moderate-to-severe psoriasis (typically PASI score 10 or above, or significant quality-of-life impact) who have not responded adequately to conventional treatments such as methotrexate or cyclosporine, or who have contraindications to these agents. Assessment, prescription, and monitoring of biologics psoriasis india is done under dermatologist supervision with regular clinical review and safety monitoring.
Q7. Where is the clinic located in South Delhi?
S-79, Greater Kailash Part-1, New Delhi 110048. Accessible from Greater Kailash, Hauz Khas, Defence Colony, Lajpat Nagar, Malviya Nagar, Saket, and Green Park. Open Monday to Saturday, 9am to 8pm. +91 9315479193.